References
- Lepper MH, Wolfe CK, Zimmerman HJ, Caldwell ER, Spies HW, Dowling HF. Effect of large doses of aureomycin on the human liver. Arch Intern Med 1951; 88: 271–83
- Schultz JC, Adamson JS, Wayne WW, Norman TD. Fatal liver disease after intravenous administration of tetracycline in high dosage. N Engl J Med 1963; 269: 999–1004
- Wruble LD, Ladman AJ, Britt LG, Cummins AJ. Hepatotoxicity produced by tetracycline. JAMA 1965; 192: 6
- Peters RL, Edmonson HA, Mikkelsen WP, Tatter D. Tetra-cycline-induced fatty liver in non-pregnant patients. A report of 6 cases. Am J Surg 1967; 113: 622–32
- Gough A, Chapman S, Wagstaff K, Emery P, Elias E. Minocycline induced atoimmune hepatitis and systemic lupus erythematosus-like syndrome. Br Med J 1996; 312: 169–72
- Hunt CM, Wasington K. Tetracycline-induced bile duct paucity and prolonged cholestasis. Gastroenterology 1994; 107: 1844–7
- Schrumpf E, Nordgård K. Unusual cholestatic hepatotoxicity of doxycycline in a young male. Scand J Gastroenterol 1986; 21: 68, Suppl 120
- Yeh SDJ, Shils ME. Tetracycline and incorporation of amino acids into proteins of rat tissues. Proc Soc Exp Biol Med 1966; 121: 729–34
- Hansen CH, Pearson LH, Schenker S. Impaired secretion of triglycerides by the liver. A cause of tetracycline-induced fatty liver. Proc Soc Exp Biol Med 1968; 128: 143–6
- Breen K, Schenker S, Heimberg M. Fatty liver induced by tetracyclines in the rat. Dose-response relationships and effect of sex. Gastroenterology 1975; 69: 714–23
- Schenker S, Breen K, Heimberg M. Pathogenesis of tetracycline-induced fatty liver. Drugs and the liver, W Gerok, K Sickinger, H Falk. Schattauer, Stuttgart 1975; 269–89
- Frenéeaux E, Labbe G, Letterton P, Dinh TL, Degott C, Genéve J. Inhibition of the mitochondrial oxidation of fatty acids by tetracyclines in mice and man: Possible role in microvesicular steatosis induced by this antibiotic. Hepatology 1988; 8: 1056–62
- Carson JL, Strom BL, Duff A, Gupta A, Shaw M, Lundin FE. Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines. Ann Intern Med 1993; 119: 576–83
- Nordisk Läkemedelsstatistik. Nordic statistics on medicines 1975–1977. Part II. Nordic Council on Medicines, Uppsala 1979
- Benichou C. Criteria of drug-induced liver disorders. Report of an international concensus meeting. J Hepatol 1990; 11: 272–6
- Blackburn AM, Amiel SA, Millis RR, Rubens RD. Tamoxifen and liver damage. Br Med J 1984; 289: 288
- Drerup AL, Alexander WA, Lumb GD, Cummins AJ, Clark GM. Jaundice occurring in a patient treated with chlorotiazide. N Engl J Med 1958; 259: 534–6
- Whalley PJ, Adams RH, Combes B. Tetracycline toxicity in pregnancy. JAMA 1964; 189: 357–62
- Combes B, Whalley PJ, Adams RH. Tetracycline and the liver. Progress in liver disease, Vol 4, H Popper, F Schaffner. Grune and Stratton, New York 1972; 589–96
- Wiholm BE, Olsson S. Spontaneous reporting system of ADR-cross-fertilization with register data on morbidity and drug utilization. Detection and Prevention of Adverse Reactions, H Boström, N Ljungstedt. Almqvist & Wiksell International. Skandia International Symposia, Stockholm 1984; 152–67